Oncology in Belgium

Prof. Dr. Sylvie Rottey is a distinguished oncologist with extensive experience in medical oncology, specializing in the treatment of solid tumors, breast cancer, and genetic cancer testing. She is a leading figure in oncology research and clinical practice, serving as a Medical Director at University Hospitals Leuven (UZ Leuven), one of Belgium’s top institutions for comprehensive cancer care.

Prof. Dr. Rottey focuses on delivering personalized cancer treatments that incorporate the latest advancements in genetic testing, targeted therapies, and immunotherapy. Her extensive experience includes managing complex cancer cases, particularly those requiring multidisciplinary approaches to care. Prof. Dr. Rottey’s clinical approach prioritizes evidence-based strategies, advanced diagnostic tools, and cutting-edge treatment options to ensure optimal patient outcomes.

As a well-respected educator, Prof. Dr. Rottey also holds a faculty position at the University of Leuven, where she trains the next generation of oncologists and contributes to the development of new treatment protocols. Her commitment to advancing the field of oncology is reflected in her active involvement in clinical trials and research focused on improving cancer therapies and outcomes for patients.

Dr. Aglaja De Pauw is an accomplished medical oncologist with over 10 years of experience. She is a leading figure in the field of oncology, particularly in the diagnosis and management of breast cancer and palliative care. Dr. De Pauw currently practices at Ghent University Hospital (UZ Gent), where she provides expert care for patients with complex oncological conditions, with a particular emphasis on breast cancer and palliative care.

Dr. De Pauw's clinical expertise spans a broad spectrum of oncological disorders, but her primary focus is on breast cancer care and palliative treatments. With a comprehensive understanding of oncology, she utilizes the latest in diagnostic technologies and treatment protocols, ensuring each patient receives personalized care tailored to their specific needs.

In addition to her clinical practice, Dr. De Pauw is deeply engaged in oncological research and education. As a faculty member at Ghent University, she teaches future oncologists, contributes to oncological research programs, and actively participates in the advancement of breast cancer care and palliative care innovations. Her research is particularly focused on genetic factors influencing cancer and exploring new treatments for refractory cancers.

Dr. De Pauw's compassionate approach and dedication to improving patients' quality of life make her a trusted specialist in oncology and palliative care. She regularly consults with international patients, offering expert guidance and personalized treatment plans for those affected by oncological conditions.